May 26, 2020
Chief Clinical Officer of SyncThink, Scott Anderson, discusses a
novel technology capable of identifying eye movements that indicate
the presence of certain neurological conditions.
In this episode, you’ll discover:
Most neurological conditions lack objective diagnostic tools, which means diagnoses are made only by the exclusion of others, and heavily reliant upon the patient’s reported experiences or answers on standardized questionnaires. This includes developmental conditions often labeled as learning disabilities in children, and degenerative conditions in late life, such as dementia. Until now, there has been no method for functionally measuring the brain to determine what is actually going on with patients who present with certain signs or symptoms.
For the past 15 years, Stanford neurosurgeon Dr. Ghajar has been
capturing, studying, identifying, and classifying eye movements and
correlating them with various neurological conditions in
partnership with the US Department of Defense.
With the help of today’s guest, Scott Anderson, the data gathered from this extensive research has been commercialized, and is now available as an unprecedented tool for objectively measuring evidence of neurological impairments and conditions.
The technology utilizes FDA-approved, high-fidelity, research-grade eye tracking infrared cameras and emitters built into virtual reality goggles, and conducts a series of 60-second assessments to capture eye movements.
Anderson explains the specifics of the treatments and exercises used in this field, how to improve the standard and quality care for concussions, the future of eye tracking, and more.
Tune in and visit https://syncthink.com/.